Affordable Access

deepdyve-link
Publisher Website

The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia.

Authors
  • Godwin, Colin D1, 2
  • Laszlo, George S1
  • Wood, Brent L3
  • Correnti, Colin E1
  • Bates, Olivia M1
  • Garling, Eliotte E1
  • Mao, Zhengwei J3
  • Beddoe, Mary E1
  • Lunn, Margaret C1
  • Humbert, Olivier1
  • Kiem, Hans-Peter1, 4, 5
  • Walter, Roland B6, 7, 8, 9
  • 1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • 2 Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA.
  • 3 Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • 4 Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA.
  • 5 Department of Pathology, University of Washington, Seattle, WA, USA.
  • 6 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. [email protected]
  • 7 Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. [email protected]
  • 8 Department of Pathology, University of Washington, Seattle, WA, USA. [email protected]
  • 9 Department of Epidemiology, University of Washington, Seattle, WA, USA. [email protected]
Type
Published Article
Journal
Leukemia
Publisher
Springer Nature
Publication Date
Sep 01, 2020
Volume
34
Issue
9
Pages
2479–2483
Identifiers
DOI: 10.1038/s41375-020-0755-7
PMID: 32071429
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times